Latent Tuberculosis Infection
📧 Sign up to get email alerts when something new happens for Latent Tuberculosis Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: Screening for Tuberculosis in Pregnancy [NA]
This ClinicalTrials.gov entry notes the completed status of a Queen Mary University of London study on screening for latent tuberculosis inf…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Clinical Trial of Mica [Phase 4]
An update on a Phase 4 clinical trial of Mica for latent tuberculosis infection, indicating the study is currently active but not recruiting…
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
A clinical trial update describing new strategies for assessing the persistence of viable Bacilli in latent and active tuberculosis to impro…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: COMPArison of Screening Strategies for Active TuBerculosis (COMPASS-TB)
The COMPASS-TB trial comparing screening strategies for active tuberculosis and latent tuberculosis infection has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Nurse-Led Community Health Worker Adherence Model in 3HP Delivery Among Homeless Adults at Risk for TB Infection and HIV [NA]
A completed clinical trial evaluating a nurse-led community health worker adherence model for delivering 3HP to homeless adults at risk for …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Risk of SDRs Under 3HP and 1HP Regimen for LTBI [Phase 3]
Phase 3 clinical trial update evaluating risk of serious adverse drug reactions (SDRs) with 3HP and 1HP regimens for latent tuberculosis inf…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial) [NA]
An implementation trial compared different delivery methods for the 3HP regimen (isoniazid–rifapentine) to prevent tuberculosis in individua…
-
CLINICAL_TRIALS withdrawal · 2023-10-19Clinical Trial Update: BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison Population [Phase 4]
Phase 4 trial on BCG re-vaccination for latent tuberculosis prophylaxis in prisoners was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Treatment of Latent Tuberculosis in Socially Marginalised Citizens [Phase 4]
Phase 4 clinical trial update on latent tuberculosis treatment in socially marginalised individuals, terminated.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in Patients With Kidney Transplantation: a Prospective Intervention Pilot Study [Phase 4]
A Phase 4 prospective pilot study evaluating rifamycin-containing regimens for latent tuberculosis infection in kidney transplant patients, …
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: Trial of Vitamin D Supplementation in Cape Town Primary Schoolchildren [Phase 3]
Phase 3 trial assessing vitamin D supplementation in schoolchildren for latent tuberculosis; study completed.
-
FDA approval · 2021-09-13FDA Approved: RIFAMPIN — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Rifampin (RIFAMPIN) submitted by Chartwell RX, LLC under ANDA065390.
-
FDA approval · 2020-06-09FDA Approved: PRIFTIN — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for Priftin (rifapentine) filed by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2020-06-05FDA Approved: PRIFTIN — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for PRIFTIN (rifapentine) from Sanofi-US LLC, signaling regulatory approval related to a labelin…
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis [Phase 1]
Phase 1 safety and immunogenicity study of the AERAS-456 vaccine for latent tuberculosis completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults [NA]
This clinical trial update notes that a study evaluating latent tuberculosis in second-generation immigrants from high-risk TB countries com…
-
CLINICAL_TRIALS withdrawal · 2018-04-17Clinical Trial Update: Evaluation of Diabetes Control and Effect on Transmission and Development of Tuberculosis [Phase 4]
A Phase 4 clinical trial evaluating whether diabetes control affects transmission and development of latent tuberculosis; the study has been…
-
CLINICAL_TRIALS trial_result · 2017-12-19Clinical Trial Update: Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9) [Phase 3]
Phase 3 trial comparing rifampin to isoniazid for latent tuberculosis infection in children has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-19Clinical Trial Update: Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness [Phase 3]
A Phase 3 randomized trial comparing 4RIF versus 9INH for treatment of latent tuberculosis infection has completed.
-
CLINICAL_TRIALS safety_alert · 2017-10-18Clinical Trial Update: Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection
This clinical trial update discusses adverse drug reactions observed with anti-tuberculosis drugs used to treat latent tuberculosis infectio…
-
CLINICAL_TRIALS research · 2017-07-21Clinical Trial Update: Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT [NA]
A clinical trial from Seoul National University Hospital investigates using ultra low-dose chest CT for early diagnosis of active tuberculos…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection
A clinical trial investigating immune responses to Mycobacterium tuberculosis in people with latent TB infection, with or without helminth c…
-
CLINICAL_TRIALS research · 2017-05-31Clinical Trial Update: Testing for Tuberculosis in the United Kingdom HIV Infected Population
An update on a clinical trial from University College London evaluating tuberculosis testing in HIV-infected individuals in the United Kingd…
-
CLINICAL_TRIALS research · 2017-05-05Clinical Trial Update: IGRA and Mantoux Response in Children With Suspected Latent or Active TB Infection
Clinical trial update examining IGRA (interferon-gamma release assay) and Mantoux test responses in children with suspected latent or active…
-
CLINICAL_TRIALS research · 2017-01-04Clinical Trial Update: Latent Tuberculosis Infection in Korean Health Care Workers [NA]
The study, sponsored by Hanyang University, investigates latent tuberculosis infection in Korean healthcare workers. The trial status is cur…